Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Upma Awasthi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Ophthalmology|May 25, 2019
Re: Staurenghi et al.: Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: twelve-month findings from PROMETHEUS (Ophthalmology. 2018;125:850-862)Upma Awasthi, Chetan Videkar
American Journal of Ophthalmology|May 26, 2019
Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous ChorioretinopathyUpma Awasthi, Rohini Grover, Abhishek Varshney, et al.
Retina (Philadelphia, Pa.)|March 2, 2019
CorrespondenceUpma Awasthi, Rohini Grover, Chetan Videkar, et al.
GMS Ophthalmology Cases|March 3, 2021
Post-traumatic endophthalmitis with Moraxella in a childUpma Awasthi, Rohini Grover, Chetan Videkar, et al.
Indian Journal of Ophthalmology|September 25, 2019
Comment on: The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degenerationUpma Awasthi, Rohini Grover, Chetan Videkar, et al.
Eye (London, England)|December 19, 2018
Comment on "Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks"Upma Awasthi, Rohini Grover, Chetan Videkar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Ophthalmology|May 25, 2019
Re: Staurenghi et al.: Efficacy and safety of ranibizumab 0.5 mg for the treatment of macular edema resulting from uncommon causes: twelve-month findings from PROMETHEUS (Ophthalmology. 2018;125:850-862)Upma Awasthi, Chetan Videkar
American Journal of Ophthalmology|May 26, 2019
Predictive Factors of Response to Mineralocorticoid Receptor Antagonists in Nonresolving Central Serous ChorioretinopathyUpma Awasthi, Rohini Grover, Abhishek Varshney, et al.
Retina (Philadelphia, Pa.)|March 2, 2019
CorrespondenceUpma Awasthi, Rohini Grover, Chetan Videkar, et al.
GMS Ophthalmology Cases|March 3, 2021
Post-traumatic endophthalmitis with Moraxella in a childUpma Awasthi, Rohini Grover, Chetan Videkar, et al.
Indian Journal of Ophthalmology|September 25, 2019
Comment on: The role of posterior vitreous detachment on the efficacy of anti-vascular endothelial growth factor intravitreal injection for treatment of neovascular age-related macular degenerationUpma Awasthi, Rohini Grover, Chetan Videkar, et al.
Eye (London, England)|December 19, 2018
Comment on "Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks"Upma Awasthi, Rohini Grover, Chetan Videkar, et al.
Pageof 1